Low Concordance Between T-Cell Densities in Matched Primary Tumors and Liver Metastases in Microsatellite Stable Colorectal Cancer

Abstract

BackgroundThe subtype, density and location of tumor infiltrating T-cells are being explored as prognostic and predictive biomarkers in primary colorectal cancer (pCRC) and colorectal liver metastases (CLM). Very limited data exist comparing findings in pCRC and matched CLM.Patients and methodsFifty-eight patients with available pCRC and matched CLM (57/58 microsatellite stable) were included in this OSLO-COMET substudy. In immunohistochemically stained sections, total (Ttot), helper (TH), cytotoxic (CTL), and regulatory (Treg) T-cells were manually counted in hotspots from the invasive margin (IM), intratumor (IT), and tumor adjacent regions to determine T-cell densities.ResultsA striking accumulation of T-cells was found in IM of both pCRC and CLM with much lower densities in the IT region, exemplified by Ttot of 2838 versus 340 cells/mm2, respectively, in CLM. The correlation at the individual level between T-cell densities in pCRC and corresponding CLM was poor for all regions and T-cell subtypes; for instance, the correlation coefficient (R2) for IM Ttot was 0.07. The IT TH : CTL and Treg : TH ratios were 2.94 and 0.44, respectively, in pCRC, and 1.84 and 0.24, respectively, in CLM.ConclusionThe observed accumulation of T-cells in the IM regions of pCRC and CLM with low penetration to the IT regions, combined with high TH : CTL and Treg : TH ratios, point to the presence of an immune suppressive microenvironment. T-cell densities of CLM differed markedly from the matched pCRC, indicating that to evaluate T-cell biomarkers in metastasis, the commonly available pCRC cannot serve as a surrogate for the metastatic tumor.

APRRX1Signature Identifies TIM-3 and VISTA as Potential Immune Checkpoint Targets in a Subgroup of Microsatellite Stable Colorectal Cancer Liver Metastases

“…Generally, the levels were low (median = 2.8 mg/L; min-max 0.6–45 mg/L; where nine cases had CRP levels above the 5 mg/L threshold value). All included patients had MSS tumors ( 14 ).…”

Electroporation and Immunotherapy—Unleashing the Abscopal Effect

“…Thus, intermetastatic heterogeneity, including the composition of the TME, exists among different metastatic lesions in the same patients as well as heterogeneity between the primary tumor and metastases [ 161 , 162 ]. This may be associated with the low concordance of T cell tumor infiltration between primary tumor and matched metastases seen in colorectal cancer [ 163 ]. Although typical driver gene mutations are shared by all lesions, a patient with metastatic cancer will have other critical tumor mutations that are not shared [ 164 , 165 ].…”

ICOSeg: Real-Time ICOS Protein Expression Segmentation from Immunohistochemistry Slides Using a Lightweight Conv-Transformer Network

“…Translational oncology has been improved significantly by tissue-based biomarker analysis using IHC, which maintains spatial and cell-specific information, and allows for reliable biomarker expression analysis inside the tumor micro-environment [ 5 ]. A pathologist can assess the quantification of biomarker-expressing cells and their location to provide significant prognostic patient information [ 6 , 7 ]. As a means of evaluating biomarkers in a high volume/high throughput manner, Tissue microarrays (TMA) can be incorporated into the development pipeline of biomarker research [ 8 , 9 ].…”